Literature DB >> 15862306

Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor.

Mariarosaria Naddeo1, Luigi Vitagliano, Aniello Russo, Giovanni Gotte, Giuseppe D'Alessio, Salvatore Sorrentino.   

Abstract

Ribonuclease A (RNase A) dimers have been recently found to be endowed with some of the special, i.e., non-catalytic biological activities of RNases, such as antitumor and aspermatogenic activities. These activities have been so far attributed to RNases which can escape the neutralizing action of the cytosolic RNase inhibitor (cRI). However, when the interactions of the two cytotoxic RNase A dimers with cRI were investigated in a quantitative fashion and at the molecular level, the dimers were found to bind cRI with high affinity and to form tight complexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862306     DOI: 10.1016/j.febslet.2005.03.087

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Cancer-suppressive effect of RNase A and DNase I.

Authors:  O A Shklyaeva; N L Mironova; E M Malkova; O S Taranov; E I Ryabchikova; M A Zenkova; V V Vlasov
Journal:  Dokl Biochem Biophys       Date:  2008 May-Jun       Impact factor: 0.788

2.  Genome-wide identification and quantitative analysis of cleaved tRNA fragments induced by cellular stress.

Authors:  Mridusmita Saikia; Dawid Krokowski; Bo-Jhih Guan; Pavel Ivanov; Marc Parisien; Guo-fu Hu; Paul Anderson; Tao Pan; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

3.  Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo.

Authors:  Islam Saber Ead Mohamed; Aleksandra V Sen'kova; Oleg V Markov; Andrey V Markov; Innokenty A Savin; Marina A Zenkova; Nadezhda L Mironova
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

Review 4.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

5.  A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours.

Authors:  M Borriello; P Laccetti; G Terrazzano; G D'Alessio; C De Lorenzo
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

6.  Magnetic Ionic Liquids as Solvents for RNA Extraction and Preservation.

Authors:  Chenghui Zhu; Marcelino Varona; Jared L Anderson
Journal:  ACS Omega       Date:  2020-05-05

Review 7.  Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.

Authors:  Nadezhda Mironova; Valentin Vlassov
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

Review 8.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

9.  Angiogenin cleaves tRNA and promotes stress-induced translational repression.

Authors:  Satoshi Yamasaki; Pavel Ivanov; Guo-Fu Hu; Paul Anderson
Journal:  J Cell Biol       Date:  2009-03-30       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.